94 related articles for article (PubMed ID: 31571861)
1. Delivery luteolin with folacin-modified nanoparticle for glioma therapy.
Wu C; Xu Q; Chen X; Liu J
Int J Nanomedicine; 2019; 14():7515-7531. PubMed ID: 31571861
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the anti-glioma therapy of doxorubicin by honokiol with biodegradable self-assembling micelles through multiple evaluations.
Gao X; Yu T; Xu G; Guo G; Liu X; Hu X; Wang X; Liu Y; Mao Q; You C; Zhou L
Sci Rep; 2017 Feb; 7():43501. PubMed ID: 28240249
[TBL] [Abstract][Full Text] [Related]
3. Folate-targeted polymeric micelles loaded with ultrasmall superparamagnetic iron oxide: combined small size and high MRI sensitivity.
Hong GB; Zhou JX; Yuan RX
Int J Nanomedicine; 2012; 7():2863-72. PubMed ID: 22745549
[TBL] [Abstract][Full Text] [Related]
4. Preparation and Evaluation of Folate Modified PEG-PLLA Nanoparticles Loaded with Lycorine for Glioma Treatment.
Ding J; Su J; Luo B; Ding L
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474593
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled nanomicelles for oral delivery of luteolin utilizing the intestinal lymphatic pathway to target pancreatic cancer.
Karole A; Dinakar YH; Sagar P; Mudavath SL
Nanoscale; 2024 Apr; 16(15):7453-7466. PubMed ID: 38517408
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma.
Zhang M; Asghar S; Tian C; Hu Z; Ping Q; Chen Z; Shao F; Xiao Y
Carbohydr Polym; 2021 Feb; 253():117194. PubMed ID: 33278970
[TBL] [Abstract][Full Text] [Related]
7. Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.
Zou Y; Sun X; Wang Y; Yan C; Liu Y; Li J; Zhang D; Zheng M; Chung RS; Shi B
Adv Mater; 2020 Jun; 32(24):e2000416. PubMed ID: 32374446
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations.
Zhang DY; Dmello C; Chen L; Arrieta VA; Gonzalez-Buendia E; Kane JR; Magnusson LP; Baran A; James CD; Horbinski C; Carpentier A; Desseaux C; Canney M; Muzzio M; Stupp R; Sonabend AM
Clin Cancer Res; 2020 Jan; 26(2):477-486. PubMed ID: 31831565
[TBL] [Abstract][Full Text] [Related]
9. Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours.
Karlsson J; Rui Y; Kozielski KL; Placone AL; Choi O; Tzeng SY; Kim J; Keyes JJ; Bogorad MI; Gabrielson K; Guerrero-Cazares H; Quiñones-Hinojosa A; Searson PC; Green JJ
Nanoscale; 2019 Nov; 11(42):20045-20057. PubMed ID: 31612183
[TBL] [Abstract][Full Text] [Related]
10. Improving Anti-Inflammatory Effect of Luteolin with Nano-Micelles in the Bacteria-Induced Lung Infection.
Miao J; Lin F; Huang N; Teng Y
J Biomed Nanotechnol; 2021 Jun; 17(6):1229-1241. PubMed ID: 34167635
[TBL] [Abstract][Full Text] [Related]
11. Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma.
Elsayed MMA; Okda TM; Atwa GMK; Omran GA; Abd Elbaky AE; Ramadan AEH
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34063274
[TBL] [Abstract][Full Text] [Related]
12. Targeted PD-L1 PLGA/liposomes-mediated luteolin therapy for effective liver cancer cell treatment.
Cao X; Wang B
J Biomater Appl; 2021 Nov; 36(5):843-850. PubMed ID: 34000859
[TBL] [Abstract][Full Text] [Related]
13. Nanoemulsion Vehicles as Carriers for Follicular Delivery of Luteolin.
Shin K; Choi H; Song SK; Yu JW; Lee JY; Choi EJ; Lee DH; Do SH; Kim JW
ACS Biomater Sci Eng; 2018 May; 4(5):1723-1729. PubMed ID: 33445329
[TBL] [Abstract][Full Text] [Related]
14. Luteolin-loading of Her-2-poly (lactic-co-glycolic acid) nanoparticles and proliferative inhibition of gastric cancer cells via targeted regulation of forkhead box protein O1.
Ding J; Li Q; He S; Xie J; Liang X; Wu T; Li D
J Cancer Res Ther; 2020; 16(2):263-268. PubMed ID: 32474511
[TBL] [Abstract][Full Text] [Related]
15. New insights into targeted therapy of glioblastoma using smart nanoparticles.
Ghaznavi H; Afzalipour R; Khoei S; Sargazi S; Shirvalilou S; Sheervalilou R
Cancer Cell Int; 2024 May; 24(1):160. PubMed ID: 38715021
[TBL] [Abstract][Full Text] [Related]
16. Exploiting Nanotechnology for Drug Delivery: Advancing the Anti-Cancer Effects of Autophagy-Modulating Compounds in Traditional Chinese Medicine.
Liu Z; Lu T; Qian R; Wang Z; Qi R; Zhang Z
Int J Nanomedicine; 2024; 19():2507-2528. PubMed ID: 38495752
[TBL] [Abstract][Full Text] [Related]
17. Application of nanomaterials in the treatment of intracerebral hemorrhage.
Zhang X; Khan S; Wei R; Zhang Y; Liu Y; Wee Yong V; Xue M
J Tissue Eng; 2023; 14():20417314231157004. PubMed ID: 37032735
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Luteolin on Cancer.
Çetinkaya M; Baran Y
Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992138
[TBL] [Abstract][Full Text] [Related]
19. Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles.
Zhu Y; Zhang W; Chen J
Drug Des Devel Ther; 2023; 17():1-13. PubMed ID: 36636745
[TBL] [Abstract][Full Text] [Related]
20. Anti-Inflammatory Mechanisms of Dietary Flavones: Tapping into Nature to Control Chronic Inflammation in Obesity and Cancer.
Kariagina A; Doseff AI
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
